In this study, we found that GPNMB expression in serum, cerebellum, and liver was decreased, accompanied by the attenuation of Purkinje cell loss and liver dysfunction by intracerebroventricular HP-β-CD treatment. The gene discussed is GPNMB; the disease is medical procedure.